PE74799A1 - Combinaciones antivirales - Google Patents
Combinaciones antiviralesInfo
- Publication number
- PE74799A1 PE74799A1 PE1998000375A PE00037598A PE74799A1 PE 74799 A1 PE74799 A1 PE 74799A1 PE 1998000375 A PE1998000375 A PE 1998000375A PE 00037598 A PE00037598 A PE 00037598A PE 74799 A1 PE74799 A1 PE 74799A1
- Authority
- PE
- Peru
- Prior art keywords
- reverse transcriptase
- inhibitors
- composition
- hiv protease
- inhibitor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
CARACTERIZADA PORQUE COMPRENDE (-)-(1S,4R)-4-[2-AMINO-6-(CICLOPROPILAMINO)-9H-PURIN-9-IL]-2-CICLOPENTEN-1-METANOL (1592U89) Y UNO O MAS INHIBIDORES DE TRANSCRIPTASA INVERSA NO NUCLEOSIDO EN PARTICULAR NEVIPARINA, LOVIRIDINA, DESLAVURIDINA, 2(S)-7-FLUORO-3,4-DIHIDRO-2-ETIL-3-OXO-1-(2H)-QUINOXALIN CARBOXILATO DE ISOPROPILO (HBY-1293) TAMBIEN LA COMPOSICION PUEDE CONTENER UN INHIBIDOR DE TRANSCRIPTASA INVERSA O UN INHIBIDOR DE PROTEASA DEL VIH. LA COMPOSICION PUEDE SER UTIL PARA EL TRATAMIENTO DE UNA INFECCION POR VIH RESISTENTE A LOS INHIDORES DE LA TRANSCRIPTASA INVERSA, NUCLEOSIDOS O INHIBIDORES DE PROTEASA DEL VIH
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9709945.1A GB9709945D0 (en) | 1997-05-17 | 1997-05-17 | A novel salt |
GBGB9719883.2A GB9719883D0 (en) | 1997-09-19 | 1997-09-19 | Antiviral combinations |
Publications (1)
Publication Number | Publication Date |
---|---|
PE74799A1 true PE74799A1 (es) | 1999-08-13 |
Family
ID=26311543
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE1998000375A PE74799A1 (es) | 1997-05-17 | 1998-05-14 | Combinaciones antivirales |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0979082A1 (es) |
JP (1) | JP2001525839A (es) |
AR (1) | AR012702A1 (es) |
AU (1) | AU7912398A (es) |
BR (1) | BR9809127A (es) |
CA (1) | CA2289655A1 (es) |
CO (1) | CO4950569A1 (es) |
HR (1) | HRP980264A2 (es) |
MA (1) | MA26496A1 (es) |
NO (1) | NO995620L (es) |
PE (1) | PE74799A1 (es) |
WO (1) | WO1998052570A1 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HRP990030A2 (en) * | 1998-02-17 | 1999-10-31 | Michael B. Maurin | Oral liquid formulations of benzoxazinones hiv reverse transcriptase inhibitors |
US20010014352A1 (en) | 1998-05-27 | 2001-08-16 | Udit Batra | Compressed tablet formulation |
EP1332757B1 (en) * | 1998-05-27 | 2012-06-13 | Merck Sharp & Dohme Corp. | Efavirenz compressed tablet formulation |
CO5070643A1 (es) * | 1998-05-27 | 2001-08-28 | Merck & Co Inc | Formulacion en tabletas comprimidas |
WO2013111147A1 (en) * | 2011-12-19 | 2013-08-01 | Hetero Research Foundation | Extended release compositions of nevirapine |
EP2962693B1 (en) * | 2013-02-27 | 2019-01-09 | Kyoto University | Pharmaceutical composition comprising abacavir for the treatment of cancer |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9417249D0 (en) * | 1994-08-26 | 1994-10-19 | Wellcome Found | A novel salt |
MY115461A (en) * | 1995-03-30 | 2003-06-30 | Wellcome Found | Synergistic combinations of zidovudine, 1592u89 and 3tc |
-
1998
- 1998-05-14 AR ARP980102250A patent/AR012702A1/es unknown
- 1998-05-14 CA CA002289655A patent/CA2289655A1/en not_active Abandoned
- 1998-05-14 AU AU79123/98A patent/AU7912398A/en not_active Abandoned
- 1998-05-14 BR BR9809127-1A patent/BR9809127A/pt not_active Application Discontinuation
- 1998-05-14 PE PE1998000375A patent/PE74799A1/es not_active Application Discontinuation
- 1998-05-14 WO PCT/EP1998/002836 patent/WO1998052570A1/en not_active Application Discontinuation
- 1998-05-14 EP EP98929309A patent/EP0979082A1/en not_active Withdrawn
- 1998-05-14 JP JP54991198A patent/JP2001525839A/ja active Pending
- 1998-05-15 MA MA25076A patent/MA26496A1/fr unknown
- 1998-05-15 HR HR9719883.2A patent/HRP980264A2/hr not_active Application Discontinuation
- 1998-05-15 CO CO98027484A patent/CO4950569A1/es unknown
-
1999
- 1999-11-16 NO NO995620A patent/NO995620L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
HRP980264A2 (en) | 1999-02-28 |
CA2289655A1 (en) | 1998-11-26 |
AU7912398A (en) | 1998-12-11 |
WO1998052570A1 (en) | 1998-11-26 |
BR9809127A (pt) | 2000-08-01 |
CO4950569A1 (es) | 2000-09-01 |
JP2001525839A (ja) | 2001-12-11 |
AR012702A1 (es) | 2000-11-08 |
EP0979082A1 (en) | 2000-02-16 |
NO995620L (no) | 2000-01-14 |
MA26496A1 (fr) | 2004-12-20 |
NO995620D0 (no) | 1999-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2174992T3 (es) | Productos intermediarios para la obtencion de compuestos inhibidores de proteasas retrovirales. | |
MY142948A (en) | Benzophenones as inhibitors of reverse transcriptase | |
NO950670L (no) | N-(alkanoylamino-2-hydroksypropyl)sulfonamider som er nyttige som retrovirale proteaseinhibitorer | |
MX9403380A (es) | Inhibidores de proteasa de vih utiles para el tratamiento de sida. | |
DK0656888T3 (da) | Sulfonylalkanoylaminohydroxyethylaminosulfonamider, anvendelige som retrovirale protease-inhibitorer | |
CL2004002061A1 (es) | Compuestos derivados de heterociclos condensados que contienen nitrogeno; composicion farmaceutica; y su uso como agente antiviral, inhubidor de integrasa y como agente anti-vih. | |
ES2177868T3 (es) | Hidroxietilaminosulfonamidas de alfa- y beta-aminoacidos utiles como inhibidores de proteasas retroviricas. | |
DE69333378D1 (de) | Pharmazeutische zusammensetzungen mit interleukin-1 inhibitoren | |
BR0211390A (pt) | Tratamento de infecções da unha com no | |
NO20052159L (no) | Substituert (tiazol-2-yl)-amid eller sulfonamid som glykokinase-aktivatorer nyttige ved behandling av type 2 diabetes. | |
CO5180587A1 (es) | Composicion farmaceutica de orlistat que contiene tensoactivos y dispersantes | |
ES2174921T3 (es) | Inhibidores de la proteasa del vih. | |
AR009145A1 (es) | Compuetos heterociclicos de guanidinilo utiles como agonistas de alfa-2 adrenoreceptores y composiciones farmaceuticas que los comprenden | |
PE74799A1 (es) | Combinaciones antivirales | |
NO993670L (no) | Quinoksalin i trippelkombinasjon med proteaseinhibitorer og reverse transkriptaseinhibitorer som medikamenter for behandling av AIDS | |
PA8461601A1 (es) | Isoquinolinas | |
ES2103493T3 (es) | Uso de parathormona, de sus fragmentos biologicamente activos y de peptidos relacionados para el tratamiento del embarazo. | |
ES2164724T3 (es) | Uso de una enzima para preparar un agente para el tratamiento y/o la profilaxis de la coccidiosis. | |
AR049560A2 (es) | Formas cristalinas de (2s,3s,5s)-2-(2,6-dimetilfenoxiacetil) amin 3-hidroxi-5-(2-(1-tetrahidropirimid-2-onil)-3-metilbutanol)amin-1,6-difenilhexano (lopinavir) | |
DK0669803T3 (da) | Anvendelse af amidoaminer i ophthalmologiske sammensætninger | |
EA199700150A1 (ru) | КОМБИНИРОВАННОЕ ЛЕЧЕНИЕ ПО ПОВОДУ ВИЧ ИНФЕКЦИИ С ИСПОЛЬЗОВАНИЕМ ИНГИБИТОРА ПРОТЕАЗЫ ВИЧ ИНДИНАВИРА И ИНГИБИТОРА ОБРАТНОЙ ТРАНСКРИПТАЗЫ 3TC, НЕОБЯЗАТЕЛЬНО СОВМЕСТНО С AZT, ddI ИЛИ ddC | |
ATE253938T1 (de) | Pharmazeutische kombination von antiviralen wirkstoffen | |
PE20000020A1 (es) | Composiciones para el tratamiento del sida e infeccion del vih | |
ATE238062T1 (de) | Hemmung von hiv-infektion | |
ES2036697T3 (es) | Lente de contacto esferica para la correccion de la presbicia. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |